维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Passauer"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilatation in normotensive patients on chronic hemodialysis显示文摘	Passauer J Btissemaker E Range	2000	J Am Soc Nephro12000，11，：	1
2	In type 2 diabetes, rosiglita-zone therapy for insulin resistance ameliorates endothelial dysfunctionindependent of glucose control 显示文摘	F Pistrosch Passauer J Fischer S	2004	Diabetes Care2004，27，2：	1
3	In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control 显示文摘	Pistrosch F Passauer J Fischer S	2004	Diabetes Care2004，27，2：	1
4	Effect of Thiazolidinedione Treatment on Proteinuria and Renal Hemodynamic in Type 2 Diabetic Patients with Overt Nephropathy显示文摘	F. Pistrosch J. Passauer K. Herbrig U. Schwanebeck P. Gross S. Bornstein	2012	Horm Metab Res2012，，12：	1
5	Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilatation in normotensive patients on chronic hemodialysis显示文摘	Passauer J Btlssemaker E Range U	2000	J Am Soc Nephrol2000，11，8：	1
6	In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endo-thelial dysfunction independent of glucose control显示文摘	PISTROSCH F PASSAUER J FISCHER S	2004	Diabetes Care2004，27，2：	1
7	In type2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘	Pistrosch F Passauer J Fischer S	2004	Diabetes Care2004，27，2：	1
8	In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘	Pistrosch F Passauer J Fischer S		0，，02：	1
9	Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedanee spectroscopy: a cross-sectional study 显示文摘	Passauer J Petrov H Schleser A	2010	Nephrol Dial Transplant2010，25，2：	1
10	In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘	Passauer J Fischer S	2004	Diabetes Care2004，27，2：	1
11	Nitric oxi-de in chronic renal failure显示文摘	PASSAUER J PISTROSCH F BUSSEMAKER E	2005	Kidney Int2005，67，5：	1
12	Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy:a cross-sectional study显示文摘	Passauer J Petrov H Schleser A		0，，：	1
13	Nitric oxide in chronic renal failure显示文摘	Frank Pistrosch Eckhart Bussemaker	2005	Kidney Int2005，67，：	1
14	In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘	Pistrosch F Passauer J Fischer S	2004	Diabetes Care2004，27，2：	1
15	In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control显示文摘	Pistrosch F Passauer J Fischer S	2004	Diabetes Care2004，27，2：	1
16	Evaluation of clinical dry weight assessment in haemodialysis patients by bioimpedance-Spectroscopy:a cross-sectional study显示文摘	Passauer J Schleser A Leicht J		0，，：	1
17	Synthesis and characterisati- on of starch phosphates 显示文摘	Passauer L Bender H Fischer S	2010	Carbohydrate Polymers2010，82，3：	1
18	Synthesis and characterisation of starch phosphates显示文摘	Lars Passauer Hans Bender Steffen Fischer	2010	Carbohydrate Polymers2010，82，：	1
19	Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilatation in normotensive patients on chronic hemodialysis显示文摘	Passauer J Bussemaker E Range	2000	J Am Soc Nephrol2000，11，：	1
20	In type 2 diabetes,rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control 显示文摘	Passauer J Fischer S	2004	Diabetes Care2004，27，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示